About SweetBio
SweetBio is a company based in Memphis (United States) founded in 2015 by Kevin Graff, Kayla Rodriguez, and Isaac Rodriguez.. SweetBio has raised $16.92 million across 8 funding rounds from investors including Delta Regional Authority, The JumpFund and MB Venture Partners. SweetBio offers products and services including APIS and VERIS. SweetBio operates in a competitive market with competitors including Imbed Biosciences, Cresilon, Kane Biotech, Alafair Biosciences and Lohmann & Rauscher, among others.
- Headquarter Memphis, United States
- Founders Kevin Graff, Kayla Rodriguez, Isaac Rodriguez
-
Sectors
Healthcare
-
Email
***********
-
Phone
*********
-
Website
*********
-
Social
*********
- Legal Name Sweetbio Inc
-
Annual Revenue
-
Net Profit
-
EBITDA
-
Total Equity Funding
$16.92 M (USD)
in 8 rounds
-
Latest Funding Round
$8.1 M (USD), Series B
Dec 01, 2022
-
Investors
Delta Regional Authority
& 5 more
-
Employee Count
Employee Count
Unlock complete access to The Company Check
Get unrestricted viewing across everything we track — from companies and brands to investors, funding rounds, acquisitions, financials, and more.
- Unlimited viewing on all profiles Companies, investors, financials, funding, acquisitions & directors
- Full access to every database India & global coverage, advanced filters and rich profile details
- Always-on access from your team account Single premium plan for everything you see on the portal
Products & Services of SweetBio
SweetBio offers a comprehensive portfolio of products and services, including APIS and VERIS. The company's diverse product and service offerings are designed to meet the evolving needs of its customers, address market demands, and provide comprehensive solutions that drive value creation and customer satisfaction across various segments and use cases.
Slow dissolve sheet for treating chronic wounds like diabetic ulcers.
Quick dissolve pad for managing acute wounds from surgery or injuries.
Unlock access to complete
Unlock access to complete
Funding Insights of SweetBio
SweetBio has successfully raised a total of $16.92M across 8 strategic funding rounds. The most recent funding activity was a Series B round of $8.1 million completed in December 2022. This substantial capital infusion reflects strong investor confidence in the company's business model, growth potential, and market opportunities. The funding enables strategic expansion, product development, market penetration, and operational scaling to drive long-term value creation and competitive advantage.
- Total Funding Total Funding
- Total Rounds 8
- Last Round Series B — $8.1M
-
First Round
First Round
(11 May 2015)
- Investors Count 6
| Date | Amount | Transaction Name | Valuation | Lead Investors | Investors |
|---|---|---|---|---|---|
| Dec, 2022 | Amount | Series B - SweetBio | Valuation |
investors |
|
| Oct, 2020 | Amount | Series A - SweetBio | Valuation |
investors |
|
| Sep, 2019 | Amount | Series A - SweetBio | Valuation |
investors |
|
| Date | Amount | Transaction Name | Valuation | Lead Investors | Investors |
|---|---|---|---|---|---|
| Jul, 2021 | Amount | Post-IPO - Grab | Valuation |
investors |
|
| Feb, 2021 | Amount | Post-IPO - Grab | Valuation |
investors |
|
| Jan, 2021 | Amount | Post-IPO - Grab | Valuation |
investors |
|
| Feb, 2021 | Amount | Post-IPO - Grab | Valuation |
investors |
Investors in SweetBio
SweetBio has secured backing from 6 investors, including venture fund and institutional investors. Prominent investors backing the company include Delta Regional Authority, The JumpFund and MB Venture Partners. This diverse investor base provides strategic capital, industry expertise, and valuable network connections that support the company's growth initiatives, market expansion, and long-term value creation.
| Investor | Description | Founded Year | Domain | Location |
|---|---|---|---|---|
|
-
|
Founded Year | Domain | Location | |
|
Capital and strategic direction are provided to life science companies.
|
Founded Year | Domain | Location | |
|
Early-stage MedTech founders are supported through accelerator programs.
|
Founded Year | Domain | Location |
| Investor | Description | Founded Year | Domain | Location |
|---|---|---|---|---|
|
Single family office of Amitabh Bachchan, founder of Amitabh Bachchan Corporation or AB CORP
|
Founded Year | Domain | Location | |
|
Startup ecosystems are ignited through strategic investments by Signite Partners.
|
Founded Year | Domain | Location | |
|
Venture capital is directed toward companies in multiple sectors.
|
Founded Year | Domain | Location | |
|
Venture capital is invested in cybersecurity, fintech, and AI startups.
|
Founded Year | Domain | Location |
Investments & Acquisitions by SweetBio
| Company Name | Description | Domain | Location | Founded Year | Amount |
|---|---|---|---|---|---|
|
Bionic investment advisor platform
|
2016 | ||||
|
Fine Asian gourmet food is offered by an internet-first restaurant.
|
2016 | ||||
|
Physical e-commerce kiosks are deployed for rural purchases in Indonesia.
|
2014 | ||||
|
Fine Asian gourmet food is offered by an internet-first restaurant.
|
2016 |
Financial Statements - SweetBio
| Date | Amount | Transaction Name | Valuation | Lead Investors | Investors |
|---|---|---|---|---|---|
| Jul, 2021 | Amount | Post-IPO - Grab | Valuation |
investors |
|
| Feb, 2021 | Amount | Post-IPO - Grab | Valuation |
investors |
|
| Jan, 2021 | Amount | Post-IPO - Grab | Valuation |
investors |
|
| Feb, 2021 | Amount | Post-IPO - Grab | Valuation |
investors |
Sweetbio Comparisons
Competitors of SweetBio
SweetBio operates in a dynamic and competitive business environment, facing competition from various established players and emerging companies in the market. The competitive landscape includes prominent companies such as Imbed Biosciences, Cresilon, Kane Biotech, Alafair Biosciences and Lohmann & Rauscher, among others. This competitive environment drives innovation, market differentiation, and strategic positioning as companies strive to capture market share and deliver value to their customers. Understanding the competitive dynamics is crucial for assessing market positioning, identifying growth opportunities, and navigating the challenges inherent in a competitive marketplace.
| Company Name | Domain | Founded year | HQ Location | Description |
|---|---|---|---|---|
| domain | founded_year | HQ Location |
Nanotech-based wound care products are developed and provided.
|
|
| domain | founded_year | HQ Location |
Developer of hemostatic products for wound care
|
|
| domain | founded_year | HQ Location |
Therapeutic solutions for biofilm prevention and removal are developed.
|
|
| domain | founded_year | HQ Location |
Biomaterials and devices for internal wound healing are developed.
|
|
| domain | founded_year | HQ Location |
Dressing materials and medical devices
|
| Company Name | Domain | Founded year | HQ Location | Description |
|---|---|---|---|---|
| domain | founded_year | HQ Location |
Multiple services are booked via an app-based platform.
|
|
| domain | founded_year | HQ Location |
On-demand services are booked through an app-based platform.
|
|
| domain | founded_year | HQ Location |
App based platform offering on demand delivery and ride-hailing services
|
|
| domain | founded_year | HQ Location |
Operates an on-demand hyperlocal delivery app for food and groceries.
|
Frequently Asked Questions about SweetBio
When was SweetBio founded?
SweetBio was founded in 2015.
Where is SweetBio located?
SweetBio is headquartered in Memphis, United States. It is registered at Memphis, Tennessee, United States.
Who is the current CEO of SweetBio?
Kayla Rodriguez is the current CEO of SweetBio. They have also founded this company.
Is SweetBio a funded company?
SweetBio is a funded company, having raised a total of $16.92M across 8 funding rounds to date. The company's 1st funding round was a Series A of $803.6K, raised on May 11, 2015.
What does SweetBio do?
SweetBio was founded in 2015 and is based in Memphis, United States. Therapies for wound healing in oral surgery are developed, along with products for acute and chronic wounds. VERIS is offered for acute wounds in skin cancer surgery and orthopedics, while APIS is provided for chronic wounds such as diabetic ulcers. Operations focus on the biotechnology sector for medical applications.
Who are the top competitors of SweetBio?
SweetBio's top competitors include Imbed Biosciences, Cresilon and Kane Biotech.
What products or services does SweetBio offer?
SweetBio offers APIS and VERIS.
Who are SweetBio's investors?
SweetBio has 6 investors. Key investors include Delta Regional Authority, The JumpFund, MB Venture Partners, ZeroTo510, and Innova Memphis.